Nieuwkerk PT - Search Results

1

Impact of comorbidity and ageing on health-related quality of life in HIV-positive and HIV-negative individuals.

Langebeek N, Kooij KW, Wit FW, Stolte IG, Sprangers MAG, Reiss P, Nieuwkerk PT; AGEhIV Cohort Study Group. Langebeek N, et al. Among authors: nieuwkerk pt. AIDS. 2017 Jun 19;31(10):1471-1481. doi: 10.1097/QAD.0000000000001511. AIDS. 2017. PMID: 28574965

2

Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response.

Nieuwkerk P, Gisolf E, Sprangers M, Danner S; Prometheus Study Group. Nieuwkerk P, et al. Antivir Ther. 2001 Jun;6(2):97-103. Antivir Ther. 2001. PMID: 11491422 Clinical Trial.

3

Lettinga KD, Verbon A, Nieuwkerk PT, Jonkers RE, Gersons BP, Prins JM, Speelman P. Lettinga KD, et al. Among authors: nieuwkerk pt. Clin Infect Dis. 2002 Jul 1;35(1):11-7. doi: 10.1086/340738. Epub 2002 Jun 7. Clin Infect Dis. 2002. PMID: 12060869

4

Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.

van der Valk M, Casula M, Weverlingz GJ, van Kuijk K, van Eck-Smit B, Hulsebosch HJ, Nieuwkerk P, van Eeden A, Brinkman K, Lange J, de Ronde A, Reiss P. van der Valk M, et al. Antivir Ther. 2004 Jun;9(3):385-93. Antivir Ther. 2004. PMID: 15259901 Clinical Trial.

5

Patients' preferences regarding the timing of highly active antiretroviral therapy initiation for chronic asymptomatic HIV-1 infection.

Locadia M, van Grieken RA, Prins JM, de Vries HJ, Sprangers MA, Nieuwkerk PT. Locadia M, et al. Among authors: nieuwkerk pt. Antivir Ther. 2006;11(3):335-41. Antivir Ther. 2006. PMID: 16759050

6

Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia.

El Moussaoui R, Opmeer BC, de Borgie CA, Nieuwkerk P, Bossuyt PM, Speelman P, Prins JM. El Moussaoui R, et al. Chest. 2006 Oct;130(4):1165-72. doi: 10.1378/chest.130.4.1165. Chest. 2006. PMID: 17035452 Clinical Trial.

7

Are retrospective measures of change in quality of life more valid than prospective measures?

Nieuwkerk PT, Tollenaar MS, Oort FJ, Sprangers MA. Nieuwkerk PT, et al. Med Care. 2007 Mar;45(3):199-205. doi: 10.1097/01.mlr.0000246613.49214.46. Med Care. 2007. PMID: 17304076

8

Quality of life after starting highly active antiretroviral therapy for chronic HIV-1 infection at different CD4 cell counts.

Nieuwkerk PT, Hillebrand-Haverkort ME, Vriesendorp R, Frissen PH, de Wolf F, Sprangers MA; ATHENA Study Group. Nieuwkerk PT, et al. J Acquir Immune Defic Syndr. 2007 Aug 15;45(5):600-1. doi: 10.1097/QAI.0b013e318074efbf. J Acquir Immune Defic Syndr. 2007. PMID: 17704686 No abstract available.

9

Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort.

de Boer-van der Kolk IM, Sprangers MA, van der Ende M, Schreij G, de Wolf F, Nieuwkerk PT. de Boer-van der Kolk IM, et al. Among authors: nieuwkerk pt. J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):460-2. doi: 10.1097/QAI.0b013e318186eefe. J Acquir Immune Defic Syndr. 2008. PMID: 19011424 No abstract available.

10

Each measure of patient-reported change provides useful information and is susceptible to bias: the need to combine methods to assess their relative validity.

Nieuwkerk PT, Sprangers MA. Nieuwkerk PT, et al. Arthritis Rheum. 2009 Dec 15;61(12):1623-5. doi: 10.1002/art.25030. Arthritis Rheum. 2009. PMID: 19950309 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters